Stephen J. Kron to Drug Screening Assays, Antitumor
This is a "connection" page, showing publications Stephen J. Kron has written about Drug Screening Assays, Antitumor.
Connection Strength
0.485
-
A bead-based activity screen for small-molecule inhibitors of signal transduction in chronic myelogenous leukemia cells. Mol Cancer Ther. 2010 May; 9(5):1469-81.
Score: 0.352
-
Quantifying the sensitivities of EGF receptor (EGFR) tyrosine kinase inhibitors in drug resistant non-small cell lung cancer (NSCLC) cells using hydrogel-based peptide array. Biosens Bioelectron. 2010 Oct 15; 26(2):424-31.
Score: 0.090
-
Targeted Covalent Inhibition of Telomerase. ACS Chem Biol. 2020 03 20; 15(3):706-717.
Score: 0.043